undamentalytics Newsletter
Sign in

Bone Biologics Corp revenue

Bone Biologics Corp's revenue was $1.07bn in fiscal 2020, up 0.0% on the year before. Over the last twelve months it was $1.07bn.

Revenue history

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2016Dec 20162019Dec 20192020Dec 2020LTMJun 2021
Revenue1,0701,0701,0701,070
Growth on the year before—0.0%0.0%—

Revenue as reported in the company's 10-K and 10-Q filings (for banks, net interest income plus non-interest income). Growth is left blank when the earlier figure was zero or negative.

Revenue against peers

Health Care Equipment: the closest covered companies by revenue. Last twelve months.

CompanyRevenueGrowth3-year growth a year
Bone Biologics Corp $1.07bn — —
Tandem Diabetes Care Inc $1.04bn 4.0% 9.6%
Inspire Medical Systems, Inc. $881m -0.2% 15.6%
Varex Imaging Corp $865m 5.3% -1.2%
Stevanato Group S.p.a. $1.34bn 12.3% —
Haemonetics Corp $1.35bn 0.4% 3.5%

Compare with peers

More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies

Figures from Bone Biologics Corp's SEC filings (10-K and 10-Q), retrieved November 1, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Bone Biologics Corp.